We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

IMPAX, Schering-Plough Settles Claritin-D 24-Hour Patent Suit

Law360 (October 27, 2003, 12:00 AM EST) -- Schering-Plough settled its patent lawsuit against generic drug maker IMPAX Laboratories, IMPAX said Monday.

As part of the agreement, IMPAX Laboratories entered into license agreement with Schering-Plough related to IMPAX's generic version of Claritin-D 24-Hour (Loratadine and Pseudoephedrine Sulfate, 10mg/240mg) Extended Release Tablets.

The agreement resolves all of the outstanding patent litigation between the parties on this product, IMPAX said.

"This case is currently at the summary motion phase and now, with this settlement, we can eliminate any additional expense or delays due to this lawsuit,"...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.